ITGAM and Hyperglycemia: Quantification data revealed a 6%, 37%, and 44% decrease in CD11b-stained cells and a 31%, 66%, and 72% decrease in F4/80-stained cells at 7, 14, and 28 days of hyperglycemia as compared to normoglycemic mice.